6. Colfax Corp. – Medical Technology segment (DJO)
6. Colfax Corp. – Medical Technology segment (DJO)2020 revenue: $1.121B*
DJO headquarters: Dallas
Colfax had major news in March: The company will split into two publicly traded companies in early 2022 — with businesses including DJO forming a new, stand-alone orthopedic device company. The split will create a to-be-named medical device company headquartered in Wilmington, Del., with a significant presence in Dallas. Current Colfax CEO Matt Trerotola will lead the medtech business.
The company expects the medical technology segment to reach $1.4 billion in revenue this year.
Colfax acquired DJO for $3.15 billion in early 2019. The business further expanded last year when Stryker sold its total ankle replacements and finger joint implants businesses to Colfax/DJO to appease U.S. and U.K. antitrust regulators as part of Stryker’s merger with Wright Medical.
* An entire year of 2019 revenues was not available.
